Curis Inc. - Curis, Inc

Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer.

OVERVIEW

The website curis.com presently has a traffic classification of zero (the lower the more traffic). We have parsed thirteen pages inside the website curis.com and found twenty-six websites interfacing with curis.com. We were able to find one contacts and locations for curis.com to help you contact them. The website curis.com has been online for one thousand four hundred and twenty-five weeks, twenty-four days, seventeen hours, and fifty-four minutes.
Pages Parsed
13
Links to this site
26
Contacts
1
Addresses
1
Online Since
Mar 1997

CURIS.COM TRAFFIC

The website curis.com is seeing variant levels of traffic for the whole of the year.
Traffic for curis.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for curis.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for curis.com

Date Range

All time
This Year
Last Year
Last Month

CURIS.COM HISTORY

The website curis.com was first recorded on March 13, 1997. This website was last updated on the date of February 19, 2013. This web page will go back on the market on March 14, 2016. It is currently one thousand four hundred and twenty-five weeks, twenty-four days, seventeen hours, and fifty-four minutes old.
REGISTERED
March
1997
UPDATED
February
2013
EXPIRED
March
2016

COMPANY LENGTH OF LIFE

27
YEARS
3
MONTHS
23
DAYS

LINKS TO WEBSITE

Investor Relations - Curis - Investor Relations

Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. CUDC-907, an orally available small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with MYC-altered diffuse large B-cell lymphoma and in a Phase 1 trial in patients with MYC-altered solid tumors.

Jims Business Investing Ideas.sugar free

I will be posting daily so visit often. Im adding some helpful links to tools and products that can help you succeed in business and in play. Remember life is too short so we need to PLAY. Monday, September 23, 2013. I hope to see you walking the Vegas S.

SoundView Technology Group Emerging Technology Research, Advisory Investing

Emerging Technology Research, Advisory and Investing. We took this moment to update the story and our model based on recent events. Learn about IPAD and IPAD. NXT-ID Ships Wocket Pre-Orders and Raises Capital. Can quality technology brands command premium margins? X000B7; Log in.

WHAT DOES CURIS.COM LOOK LIKE?

Desktop Screenshot of curis.com Mobile Screenshot of curis.com Tablet Screenshot of curis.com

CONTACTS

PERFECT PRIVACY, LLC

12808 Gran Bay Parkway West

Jacksonville, FL, 32258

US

CURIS.COM SERVER

I diagnosed that a lone root page on curis.com took one thousand three hundred and six milliseconds to load. Our parsers could not observe a SSL certificate, so in conclusion we consider curis.com not secure.
Load time
1.306 sec
SSL
NOT SECURE
IP
216.92.11.85

NAME SERVERS

ns1.earthlinkbusiness.com
ns2.earthlinkbusiness.com
ns3.earthlinkbusiness.com

WEBSITE ICON

SERVER SOFTWARE AND ENCODING

We diagnosed that this domain is operating the Apache/2.4.29 operating system.

SITE TITLE

Curis Inc. - Curis, Inc

DESCRIPTION

Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer.

PARSED CONTENT

The website had the following in the web site, "We are dedicated to developing the next generation of targeted drugs for treatment of human cancer." I viewed that the web page stated " Is a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, including oral small molecules in the fields of immuno-oncology and precision oncology." They also said " Curis Reports Fourth Quarter and Year-End 2017 Financial Results. Curis to Present at Cowen and Company 38th Annual Health Care Conference." The meta header had CRIS as the first search term. This keyword is followed by Curis, biotechnology, and drug development which isn't as important as CRIS. The other words they uses is Genentech. Amylin is included and will not be seen by web crawlers.

ANALYZE SUBSEQUENT WEB SITES

Accueil - Curis-au-Mont-dOr

Service de repas à domicile. Comité des fêtes de Curis. Les événements récurrents à Curis. Collecte et traitement des déchets. À 20 h 00 min.

Stanford CURIS

The CURIS program is a research program in Computer Science. Its goal is to encourage CS undergraduates, as well as masters students, to get involved in CS research with faculty mentors. The first is a summer program for undergraduates. Students receive a stipend or salary. The program is open to. Priority will be given to declared.

Curis au Mont dOr

Cette première édition aura permis de réunir durant ce beau dimanche ensoleillé, des producteurs passionnés, des artistes talentueux, des amateurs éclairés et des visiteurs gourmands et curieux.

Curis Benefits - Thinking outside of the Employee Benefits box

At Curis Benefits we offer a range of employee benefits products to our clients. Is one of the leading employee benefits brokerage and consulting companies in the Triangle Region of North Carolina. Since our founding, we have grown steadily to now serve both corporate and non-profit customers. Our areas of expertise encompass the design, implementation, and administration of employee benefit programs. Below is listed many of the products offered and some of the carriers we represent.